News
Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback